Help - Search - Members - Calendar
Full Version: Cirrhosis
Online Medical Forum > Library Database Of Journals Publications Researches Category > Library Database Of Journals Publications Researches > Medicine Category > Internal Medicine Forum > Medicine Topics > Cirrhosis
Pages: 1, 2, 3, 4, 5, 6, 7, 8
  1. Cirrhosis: Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study. (0 replies)
  2. Cirrhosis: Recurrence of cholestatic liver disease after living donor liver transplantation. (0 replies)
  3. Cirrhosis: Ultrasonography in differentiation between chronic viral hepatitis and compensated early stage cirrhosis. (0 replies)
  4. Cirrhosis: Hepatitis c: implications for the general physician (0 replies)
  5. Cirrhosis: Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion (0 replies)
  6. Cirrhosis: Measuring the effect of a study meal on portal concentrations of glucagon-like peptide 1 (glp-1) in non diabetic and diabetic patients with liver cirrhosis: transjugular intrahepatic portosystemic stent shunt (tipss) as a new method for me (0 replies)
  7. Cirrhosis: Role of cyclooxygenase isoforms in prostacyclin biosynthesis and murine pre-hepatic portal hypertension. (0 replies)
  8. Cirrhosis: Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy (0 replies)
  9. Cirrhosis: Survival rates and cause of death in 174 patients with chronic pancreatitis (0 replies)
  10. Cirrhosis: Editorial: predicting mortality in cirrhosis -- serum sodium helps (0 replies)
  11. Cirrhosis: Immunology: hitting 'pause' (0 replies)
  12. Cirrhosis: Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? (0 replies)
  13. Cirrhosis: Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction (0 replies)
  14. Cirrhosis: N-terminal pro b-type natriuretic peptide and the evaluation of cardiac dysfunction and severity of disease in cirrhotic patients. (0 replies)
  15. Cirrhosis: Ha/gsa-rmax ratio as a predictor of postoperative liver failure (0 replies)
  16. Cirrhosis: Potential liver damage associated with over-the-counter vitamin supplements. (0 replies)
  17. Cirrhosis: Chromogranin a levels in chronic liver disease and hepatocellular carcinoma. (0 replies)
  18. Cirrhosis: Evolution of living donor liver transplantation over 10 years: experience of a single center (0 replies)
  19. Cirrhosis: Immune responses in hepatitis c virus infection and mechanisms of hepatitis c virus persistence (0 replies)
  20. Cirrhosis: Endothelial markers in schistosomiasis patients with or without portal hypertension (0 replies)
  21. Cirrhosis: Hemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure. a prospective interventional study. (0 replies)
  22. Cirrhosis: Treatment options for patients with hepatitis c: role of pharmacists in optimizing treatment response and managing adverse events (0 replies)
  23. Cirrhosis: Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population-based cohort study (0 replies)
  24. Cirrhosis: Effects of terlipressin on the aquaretic system - evidence of antidiuretic effects. (0 replies)
  25. Cirrhosis: Immunohistochemical techniques for the demonstration of viral antigens in liver tissue (0 replies)
  26. Cirrhosis: Liver cirrhosis with synchronous gas gangrene and spontaneous bacterial peritonitis due to
    e. coli     (0 replies)
  27. Cirrhosis: Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone (0 replies)
  28. Cirrhosis: Cox-2 mediates hepatitis b virus x protein abrogation of p53-induced apoptosis. (0 replies)
  29. Cirrhosis: Interleukin-10 gene polymorphism is associated with alcoholism but not with alcoholic liver disease (0 replies)
  30. Cirrhosis: Influence of liver biopsy on abstinence in alcohol-dependent patients (0 replies)
  31. Cirrhosis: Trif and irf-3 binding to the tnf promoter results in macrophage tnf dysregulation and steatosis induced by chronic ethanol. (0 replies)
  32. Cirrhosis: Hepatocarcinoma and alcoholic cirrhosis - color ultrasound (0 replies)
  33. Cirrhosis: Hepatocarcinoma on cirrhosis - color ultrasound (0 replies)
  34. Cirrhosis: Hepatocarcinoma, cirrhosis - color ultrasound (0 replies)
  35. Cirrhosis: Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for crohn's disease in polish patients (0 replies)
  36. Cirrhosis: Animal models of nash: getting both pathology and metabolic context right (0 replies)
  37. Cirrhosis: Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis c (0 replies)
  38. Cirrhosis: Efficacy and safety of entecavir in patients with chronic hepatitis b and advanced hepatic fibrosis or cirrhosis (0 replies)
  39. Cirrhosis: [hepatology] reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis c (0 replies)
  40. Cirrhosis: [recent advances in basic science] mechanisms of extrahepatic vasodilation in portal hypertension (0 replies)
  41. Cirrhosis: Acute pancolitis after colonoscopy in liver cirrhosis patient (0 replies)
  42. Cirrhosis: Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents (0 replies)
  43. Cirrhosis: R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis (0 replies)
  44. Cirrhosis: Satavaptan improves ascites control in patients with cirrhosis (0 replies)
  45. Cirrhosis: Liver/spleen volume ratio as a predictor of prognosis in primary biliary cirrhosis (0 replies)
  46. Cirrhosis: The impact of longitudinal intestinal lengthening and tailoring on liver function in short bowel syndrome (0 replies)
  47. Cirrhosis: Satavaptan improves ascites control in patients with cirrhosis. (0 replies)
  48. Cirrhosis: Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease (0 replies)
  49. Cirrhosis: Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis c virus genotype 1 infection: a randomised controlled study (0 replies)
  50. Cirrhosis: Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? (0 replies)
  51. Cirrhosis: Prevalence and longterm course of primary biliary cirrhosis in primary sjögren's syndrome. (0 replies)
  52. Cirrhosis: Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment (0 replies)
  53. Cirrhosis: Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy (0 replies)
  54. Cirrhosis: Cd56 as a useful marker in the regenerative process of the histological progression of primary biliary cirrhosis. (0 replies)
  55. Cirrhosis: A new genetic variant involved in genetic susceptibility to alcoholic liver cirrhosis: -330t>g polymorphism of the interleukin-2 gene. (0 replies)
  56. Cirrhosis: Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis. (0 replies)
  57. Cirrhosis: Endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis. (0 replies)
  58. Cirrhosis: Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target. (0 replies)
  59. Cirrhosis: Aortic valve replacement in a patient with liver cirrhosis and coagulopathy (0 replies)
  60. Cirrhosis: Biological autoimmunity screening in hepatitis c patients by anti-hepg2 lysate and anti-heat shock protein 70.1 autoantibodies (0 replies)
  61. Cirrhosis: Biomarker selection and sample prediction for multi-category disease on maldi-tof data (0 replies)
  62. Cirrhosis: Hemodynamic studies in acute-on-chronic liver failure (0 replies)
  63. Cirrhosis: Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension (0 replies)
  64. Cirrhosis: Occult hepatitis b virus infection in patients with autoimmune liver diseases (0 replies)
  65. Cirrhosis: The risk associated with hyperoncotic colloids in patients with shock (0 replies)
  66. Cirrhosis: Osteomalacic myopathy associated with coexisting coeliac disease and primary biliary cirrhosis (0 replies)
  67. Cirrhosis: Lymphoepitelioma-like hepatocellular carcinoma: a case report and a review of the literature. (0 replies)
  68. Cirrhosis: Chronic liver disease in aboriginal north americans. (0 replies)
  69. Cirrhosis: Radiofrequency-assisted liver resection in cirrhotic patients with hepatocellular carcinoma (0 replies)
  70. Cirrhosis: Altered mesenteric venous capacitance and volume pooling in cirrhotic rats are mediated by nitric oxide (0 replies)
  71. Cirrhosis: Liver is a target of arsenic carcinogenesis (0 replies)
  72. Cirrhosis: Liver damage in hepatitis c patients could be treated with warfarin, says study (0 replies)
  73. Cirrhosis: Adaptation of hepatectomy for huge hepatocellular carcinoma (0 replies)
  74. Cirrhosis: Cytoglobin: a novel potential gene medicine for fibrosis and cancer therapy. (0 replies)
  75. Cirrhosis: A mechanism for the development of obesity-associated conditions (0 replies)
  76. Cirrhosis: Pulmonary resection for non-small cell lung cancer in patients with hepatocellular carcinoma (0 replies)
  77. Cirrhosis: Liver damage in hepatitis c patients could be treated with warfarin, says study (0 replies)
  78. Cirrhosis: Association between frequency of amino acid changes in core region of hepatitis b virus (hbv) and the presence of precore mutation in japanese hbv carriers (0 replies)
  79. Cirrhosis: Endoscopic follow-up study of development of gastric antral vascular ectasia associated with liver cirrhosis (0 replies)
  80. Cirrhosis: Prognostic factors and treatment outcome in mesenteric vein thrombosis (0 replies)
  81. Cirrhosis: Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial (0 replies)
  82. Cirrhosis: Increased flow-mediated vasodilation in cirrhotic patients with ascites: relationship with renal resistive index (0 replies)
  83. Cirrhosis: Risk factors for chronic liver disease in blacks, mexican americans, and whites in the united states: results from nhanes iv, 1999–2004 (0 replies)
  84. Cirrhosis: [evaluation of perioperative risk by anaesthesiologists.] (0 replies)
  85. Cirrhosis: Reduced expression of c/ebpα protein in hepatocellular carcinoma is associated with advanced tumor stage and shortened patient survival (0 replies)
  86. Cirrhosis: Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors. (0 replies)
  87. Cirrhosis: Direct invasion to the colon by hepatocellular carcinoma: report of two cases. (0 replies)
  88. Cirrhosis: Prospective study of bone mineral density and metabolism in patients with chronic hepatitis c during pegylated interferon α and ribavirin therapy (0 replies)
  89. Cirrhosis: Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (fibroscan) for liver fibrosis in chronic hepatitis b (0 replies)
  90. Cirrhosis: Pegylated-interferon and ribavirin in liver transplant candidates and recipients with hcv cirrhosis: systematic review and meta-analysis of prospective controlled studies (0 replies)
  91. Cirrhosis: [clinical case study] cirrhosis originally diagnosed as nonalcoholic steatohepatitis (0 replies)
  92. Cirrhosis: Donor hla-c genotype has a profound impact on the clinical outcome following liver transplantation (0 replies)
  93. Cirrhosis: Hepatic 11beta-hsd1 mrna expression in fatty liver and non-alcoholic steatohepatitis. (0 replies)
  94. Cirrhosis: Association between iron overload and osteoporosis in patients with hereditary hemochromatosis (0 replies)
  95. Cirrhosis: Prejunctional and peripheral effects of the cannabinoid cb1 receptor inverse agonist rimonabant (sr 141716) (0 replies)
  96. Cirrhosis: Spontaneous bacterial peritonitis from
    salmonella
    : an unusual bacterium with unusual presentation     (0 replies)
  97. Cirrhosis: Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type b (0 replies)
  98. Cirrhosis: The roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis b (0 replies)
  99. Cirrhosis: Systematic review: health-state utilities in liver disease: a systematic review (0 replies)
  100. Cirrhosis: Biliary cirrhosis in a child with inherited interleukin-12 deficiency (0 replies)
  101. Cirrhosis: Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis (0 replies)
  102. Cirrhosis: Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south indian subjects with hepatotropic virus and aflatoxin etiologies. (0 replies)
  103. Cirrhosis: Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion. (0 replies)
  104. Cirrhosis: Squamous cell carcinoma antigen-1 (serpinb3) polymorphism in chronic liver disease. (0 replies)
  105. Cirrhosis: Low-dose recombinant factor viia for trauma patients with coagulopathy. (0 replies)
  106. Cirrhosis: The effect of quyuhuatantongluo decoction on the non-alcoholic steatohepatitis. (0 replies)
  107. Cirrhosis: Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment. (0 replies)
  108. Cirrhosis: Deaths due to bloodborne infections and their sequelae among health-care workers (0 replies)
  109. Cirrhosis: Interferon-{alpha}2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes (0 replies)
  110. Cirrhosis: Is there a role for timely diagnosis and early anticoagulant treatment of portal vein thrombosis in patients with liver cirrhosis? (0 replies)
  111. Cirrhosis: Liver diseases and metabolic syndrome (0 replies)
  112. Cirrhosis: Splenectomy for thrombocytopenia in patients with hepatitis c cirrhosis. (0 replies)
  113. Cirrhosis: In transplants, older livers not so different than younger ones (0 replies)
  114. Cirrhosis: Necrotizing fasciitis in patients with liver cirrhosis: predominance of monomicrobial gram-negative bacillary infections. (0 replies)
  115. Cirrhosis: [letters] double-contrast mri in patients with cirrhosis (0 replies)
  116. Cirrhosis: Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis c virus-related hepatocellular carcinoma (0 replies)
  117. Cirrhosis: Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. - bajaj js, ananthakrishnan an, mcginley el, hoffmann rg, brasel kj. (0 replies)
  118. Cirrhosis: Community-acquired
    klebsiella pneumoniae
    complicated skin and soft-tissue infections of extremities: emphasis on cirrhotic patients and gas formation     (0 replies)
  119. Cirrhosis: Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis. (0 replies)
  120. Cirrhosis: [stem cell transplantation in the treatment of gastrointestinal diseases.] (0 replies)
  121. Cirrhosis: Metabolic syndrome and estimates of cardiovascular disease in cirrhotic patients (0 replies)
  122. Cirrhosis: Afp, pivkaii, gp3, scca-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease. (0 replies)
  123. Cirrhosis: Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of c-reactive protein in hispanics (0 replies)
  124. Cirrhosis: Prevalence and genotype distribution of hepatitis c virus among apparently healthy individuals in mongolia: a population-based nationwide study (0 replies)
  125. Cirrhosis: Human herpesvirus type 8 in patients with cirrhosis: correlation with sex, alcoholism, hepatitis b virus, disease severity, and thrombocytopenia. (0 replies)
  126. Cirrhosis: Hepatitis c and liver transplantation: enhancing outcomes and should patients be retransplanted. (0 replies)
  127. Cirrhosis: Microrna profile in peripheral blood t cells of patients with primary biliary cirrhosis (0 replies)
  128. Cirrhosis: Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond (0 replies)
  129. Cirrhosis: Protective effect of morin on dimethylnitrosamine-induced hepatic fibrosis in rats (0 replies)
  130. Cirrhosis: The impact of age on the demographic, clinical, radiographic characteristics and treatment outcomes of pulmonary tuberculosis patients in taiwan (0 replies)
  131. Cirrhosis: Schistosomiasis of the liver (0 replies)
  132. Cirrhosis: Schistosomiasis of the liver. (0 replies)
  133. Cirrhosis: Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial (0 replies)
  134. Cirrhosis: Hepatitis b virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations (0 replies)
  135. Cirrhosis: [recent advances in clinical practice] pathogenetic mechanisms of hepatic encephalopathy (0 replies)
  136. Cirrhosis: [postscript] bacterial translocation and cardiovascular complications of cirrhosis (0 replies)
  137. Cirrhosis: Hepatic steatosis in patients with hiv-hepatitis c virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis? (0 replies)
  138. Cirrhosis: Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. (0 replies)
  139. Cirrhosis: Primary biliary cirrhosis with a normal alkaline phosphatase: a case report (0 replies)
  140. Cirrhosis: The role of hepatic arterial flow on portal venous and hepatic venous wedged pressure in the isolated perfused ccl4-cirrhotic liver (0 replies)
  141. Cirrhosis: Successful laparoscopic splenectomy after living-donor liver transplantation for thrombocytopenia caused by antiviral therapy. (0 replies)
  142. Cirrhosis: Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. (0 replies)
  143. Cirrhosis: Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies (0 replies)
  144. Cirrhosis: [non-alcoholic fatty liver disease and cardiovascular risk.] (0 replies)
  145. Cirrhosis: Laparoscopic versus open liver resection of hepatic neoplasms: comparative analysis of short-term results (0 replies)
  146. Cirrhosis: Quantitative assessment of hepatic function and its relevance to the liver surgeon (0 replies)
  147. Cirrhosis: Lack of correlation between serum anti-hbcore detectability and hepatocellular carcinoma in patients with hcv-related cirrhosis (0 replies)
  148. Cirrhosis: Natural course of chronic hcv and hbv infection and role of alcohol in the general population: the dionysos study (0 replies)
  149. Cirrhosis: Autologous infusion of expanded mobilized adult bone marrow-derived cd34+ cells into patients with alcoholic liver cirrhosis (0 replies)
  150. Cirrhosis: Mthfr c677tt, pai1 4g-4g, v leiden q506, and prothrombin g20210a in hepatocellular carcinoma with and without portal vein thrombosis (0 replies)
This is a "lo-fi" version of our main content. To view the full version with more information, formatting and images, please click here.
Invision Power Board © 2001-2008 Invision Power Services, Inc.